Clinical Trial Update: A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial comparing oral picoplatin with intravenous picoplatin in patients with solid tumors has been completed, evaluating safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Picoplatin (intravenous) (picoplatin)
• Picoplatin (oral) (picoplatin)

Snippet

Sponsor: Poniard Pharmaceuticals | Conditions: Bladder Cancer, Breast Cancer | Phase 1 | Status: COMPLETED